...
首页> 外文期刊>Hormone and Metabolic Research >Clinical, Endocrine and Imaging Characteristics of Patients with Primary Hypophysitis
【24h】

Clinical, Endocrine and Imaging Characteristics of Patients with Primary Hypophysitis

机译:原发性衰落炎患者的临床,内分泌和成像特征

获取原文
获取原文并翻译 | 示例
           

摘要

Primary hypophysitis (PH) is a rare disease with a poorly-defined natural history. Our aim was to characterise patients with PH at presentation and during prolonged follow-up. Observational retrospective study of 22 patients was conducted from 3 centres. In 14 patients, PH was confirmed histologically and in the remaining 8 clinically, after excluding secondary causes of hypophysitis. All patients had hormonal and imaging investigations before any treatment. Median follow up was 48 months (25-75%: 3-60). There was a female predominance with a female/male ratio: 3.4:1. Eight out of 22 patients had another autoimmune disease. Headaches and gonadal dysfunction were the most common symptoms. Five patients presented with panhypopituitarism; 17 patients had anterior pituitary deficiency, and 7 had diabetes insipidus. At presentation, 9 patients were treated surgically, 5 received replacement hormonal treatment, and 8 high-dose glucocorticoids from whom 5 in association with other immunosuppressive agents. Six patients showed complete recovery of pituitary hormonal deficiencies while 6 showed a partial recovery during a 5-year follow-up period. No difference was found between patients treated with surgery and those treated medically. The overall relapse rate was 18%. PH can be manifested with a broad spectrum of clinical and hormonal disturbances. Long-term follow-up is required to define the natural history of the disease and response to treatment, since pituitary hormonal recovery or relapse may appear many years after initial diagnosis. We suggest that surgery and immunosuppressive therapy be reserved for exceptional cases.
机译:原发性衰弱性炎(pH)是一种罕见的疾病,自然历史无差。我们的宗旨是在介绍和长期随访期间表征患有pH值的患者。从3个中心进行22例患者的观察回顾性研究。在14名患者中,在排除次衰弱性炎症炎的二次原因后,在临床上,在临床上并在剩余的8患者中确认pH。所有患者在任何治疗前都有荷尔蒙和成像调查。中位后续时间为48个月(25-75%:3-60)。女性/男性比例有女性优势:3.4:1。 22例患者中有八个患有另一种自身免疫性疾病。头痛和性能障碍是最常见的症状。五名患者呈现胰腺型症; 17例患者垂体垂体缺乏,7例患有糖尿病的糖尿病。在介绍中,9例患者进行手术治疗,5名接受替代激素治疗,8名高剂量糖皮质激素,其中5个与其他免疫抑制剂相关联。 6名患者显示垂体荷尔蒙缺乏的完全恢复,而6在5年的随访期间显示出部分恢复。在手术治疗的患者和医学治疗的患者之间没有发现差异。整体复发率为18%。 pH可以表现出广谱的临床和激素紊乱。长期随访是必需的,以确定疾病的自然历史和对治疗的反应,因为初步诊断后垂体激素恢复或复发可能出现多年。我们建议手术和免疫抑制治疗保留用于特殊情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号